首页 / 院系成果 / 成果详情页

Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection A Meta-Analysis 期刊论文

编号：

fe1fce00-9cc7-4fd4-a697-27a45f179582
作者：

Hou, Yi(侯毅)#^[1]Wang, Jing(王静)^[2]Wang, Xianwen(王先文)^[2]Shi, Shaomin(石少敏)^[2]Wang, Wanli(王婉丽)^[2]Chen, Zhiying(陈志营)*^[2]
语种：

英文
期刊：

MEDICINE ISSN：0025-7974 2016 年 95 卷 2 期 ; JAN
收录：
摘要：

Cancer has been a major public health issue all over the world and cancer patients diagnosed at early stages have a comparatively favorable prognosis. The association between specific dysregulated expressed microRNA-155 (miRNA-155, miR-155) and tumorigenesis has been identified by numerous studies. However, perplexity and inconsistence arise from a wide range of studies due to heterogeneity. Therefore, this meta-analysis was carried out to validate the association between miR-155 and tumorigenesis together with the clinical applicability of miR-155.
Relevant studies were searched, identified, and selected from PubMed, Embase, Cochrane, Sinomed, and Wanfang database until July 5, 2015. Then, the sensitivity, specificity, and area under the summary receiver operator characteristic curve (AUC) were calculated to assess the overall performance miR-155 for cancer detection.
A total of 25 studies were included in the meta-analysis with a total number of 1896 cancer patients and 1226 healthy controls. The overall sensitivity and specificity was 76.8% (95%CI: 71.1-81.7%) and 82.9% (95% CI: 77.5-87.3%), respectively. In addition, the pooled AUC and partial AUC was 0.867 and 0.718, respectively. Results from subgroup analyses suggested that the diagnostic accuracy of miR-155 in the Caucasian group was significantly higher than that in the Asian group. Similarly, serum sample type may provide better diagnostic value of miR-155 than plasma. Apart from that, miR-155 in breast cancer achieved the highest accuracy compared with miR-155 in other types of cancer.
Results from meta-analysis suggested that miR-155 had great potential as a novel noninvasive biomarker for human cancer detection, particularly when breast cancer or Caucasian is involved. However, well-designed cohort or case control studies with large sample size should be implemented to confirm the diagnostic value of miR-155.
推荐引用方式
GB/T 7714：

Hou Yi,Wang Jing,Wang Xianwen, et al. Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection A Meta-Analysis [J].MEDICINE,2016,95(2).
APA：

Hou Yi,Wang Jing,Wang Xianwen,Shi Shaomin,&Chen Zhiying.(2016).Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection A Meta-Analysis .MEDICINE,95(2).
MLA：

Hou Yi, et al. "Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection A Meta-Analysis" .MEDICINE 95,2(2016).
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：45  下载次数：0

分享到：

浏览次数：45

下载次数：0

打印次数：0